{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"Esperion Hosting Virtual Research &amp; Development Day - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"eNVTHu29wb\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-hosting-virtual-research-development-day\/\">Esperion Hosting Virtual Research &amp; Development Day<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/esperion-hosting-virtual-research-development-day\/embed\/#?secret=eNVTHu29wb\" width=\"600\" height=\"338\" title=\"&#8220;Esperion Hosting Virtual Research &amp; Development Day&#8221; &#8212; Market Newsdesk\" data-secret=\"eNVTHu29wb\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"\u2013 Overview of its investigational pipeline, planned scientific focus, and future growth drivers \u2013 \u2013 Wednesday, November 9 th @ 10amET \u2013 ANN ARBOR, Mich., Oct. 27, 2022 (GLOBE NEWSWIRE) &#8212; Esperion (NASDAQ: ESPR) today announced that it will host a virtual research and development day, featuring Global Scientific Leaders C. Michael Gibson, MS, MD, from Harvard Medical Research Institutes, and Professor Peter Libby, MD, from Brigham and Women\u2019s Hospital and Harvard Medical School, who will discuss Esperion\u2019s discovery efforts and investigational programs. Esperion research and development leadership will provide an overview of its planned scientific focus and future growth drivers, including the CLEAR Outcomes trial for bempedoic acid, oral PCSK9 inhibitor, and Next Generation ATP citrate lyase inhibition (ACLYi) &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY4Mjk2MCM1MjI2MTQ4IzIwMDcxNDE="}